drugset / Trial / NCT01143974
Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
For patients resistant to enthrycycline and taxanes, there is no standard regimen. Pemetrexed alone had certain efficacy in treatment of advance breast cancer. Platin was also a effective drug for advanced breast cancer. The combination of these two drug may have a synergy with each other in treatment of advanced breast cancer.
Timeline
- Start
- 2010-06
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 80 mg/m2 | — |
| Subject | Pemetrexed | Small molecule | 500 mg/m2 | — |
Indications
No indication recorded.